AGREEMENT AND PLAN OF MERGERMerger Agreement • November 18th, 2016 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 15, 2016, by and among Marina Biotech, Inc., a Delaware corporation (“Parent”), Ithena Acquisition Corporation, a Delaware corporation (“Merger Sub”), IthenaPharma, Inc., a Delaware corporation (“Company”), and Vuong Trieu, the Company Representative. Certain capitalized terms that are used in this Agreement are defined in Section 8.1. Schedule I provides an index to certain capitalized terms that are defined in other provisions of this Agreement.
MASTER SERVICES AGREEMENTMaster Services Agreement • November 18th, 2016 • Marina Biotech, Inc. • Pharmaceutical preparations • California
This Master Services Agreement (“Agreement”) is entered into and dated as of November 15, 2016, by and between Marina Biotech Inc., a Delaware corporation (“Company”), and Autotelic Inc., a Delaware corporation (“Autotelic”).
Vuong TrieuLine of Credit Agreement • November 18th, 2016 • Marina Biotech, Inc. • Pharmaceutical preparations
Vuong Trieu (the “Lender”), hereby offers to Marina Biotech, Inc., a Delaware corporation (the “Borrower”), an unsecured line of credit (the “Line”) in an amount not to exceed $540,000 (such amount, the “Maximum Amount”). The proceeds of all advances under the Line will be used for current operating expenses of the Borrower, including the payment of the premium for the annual continuation of the Borrower’s D&O liability insurance. At the request of Lender, the Borrower shall inform the Lender of the intended use of proceeds of any advance under the Line.
